These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 16361317

  • 1. A humanized anti-human Fas antibody, R-125224, induces apoptosis in type I activated lymphocytes but not in type II cells.
    Nakayama J, Ogawa Y, Yoshigae Y, Onozawa Y, Yonemura A, Saito M, Ichikawa K, Yamoto T, Komai T, Tatsuta T, Ohtsuki M.
    Int Immunol; 2006 Jan; 18(1):113-24. PubMed ID: 16361317
    [Abstract] [Full Text] [Related]

  • 2. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
    Matsuno H, Yudoh K, Nakazawa F, Sawai T, Uzuki M, Nishioka K, Yonehara S, Nakayama J, Ohtsuki M, Kimura T.
    J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
    [Abstract] [Full Text] [Related]

  • 3. CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation.
    Mollereau B, Deckert M, Déas O, Rieux-Laucat F, Hirsch F, Bernard A, Fischer A, Lynch DH, Charpentier B, Le Deist F, Senik A.
    J Immunol; 1996 May 01; 156(9):3184-90. PubMed ID: 8617939
    [Abstract] [Full Text] [Related]

  • 4. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells.
    Ogawa Y, Ohtsuki M, Uzuki M, Sawai T, Onozawa Y, Nakayama J, Yonemura A, Kimura T, Matsuno H.
    Arthritis Rheum; 2003 Dec 01; 48(12):3350-8. PubMed ID: 14673986
    [Abstract] [Full Text] [Related]

  • 5. A noncomitogenic CD2R monoclonal antibody induces apoptosis of activated T cells by a CD95/CD95-L-dependent pathway.
    Fournel S, Robinet E, Bonnefoy-Bérard N, Assossou O, Flacher M, Waldmann H, Bismuth G, Revillard JP.
    J Immunol; 1998 May 01; 160(9):4313-21. PubMed ID: 9574534
    [Abstract] [Full Text] [Related]

  • 6. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
    Lincoln JE, Boling M, Parikh AN, Yeh Y, Gilchrist DG, Morse LS.
    Invest Ophthalmol Vis Sci; 2006 May 01; 47(5):2172-8. PubMed ID: 16639029
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of Epstein-Barr virus-induced B cell tumor to apoptosis mediated by anti-CD95/Apo-1/fas antibody.
    Durandy A, Le Deist F, Emile JF, Debatin K, Fischer A.
    Eur J Immunol; 1997 Feb 01; 27(2):538-43. PubMed ID: 9045928
    [Abstract] [Full Text] [Related]

  • 8. mHFE7A, a newly identified monoclonal antibody to Fas, induces apoptosis in human melanoma cells in vitro and delays the growth of melanoma xenotransplants.
    Hiramoto K, Inui M, Kamei T, Okumura K, Nakase M, Tagawa T.
    Oncol Rep; 2006 Feb 01; 15(2):409-15. PubMed ID: 16391862
    [Abstract] [Full Text] [Related]

  • 9. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
    Daniel PT, Krammer PH.
    J Immunol; 1994 Jun 15; 152(12):5624-32. PubMed ID: 7515909
    [Abstract] [Full Text] [Related]

  • 10. Apoptosis of human T-cells: induction by glucocorticoids or surface receptor ligation in vitro and ex vivo.
    Kirsch AH, Mahmood AA, Endres J, Bohra L, Bonish B, Weber K, Fox DA.
    J Biol Regul Homeost Agents; 1999 Jun 15; 13(2):80-9. PubMed ID: 10503730
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
    Dranitzki-Elhalel M, Huang JH, Sasson M, Rachmilewitz J, Parnas M, Tykocinski ML.
    Int Immunol; 2007 Apr 15; 19(4):355-63. PubMed ID: 17314083
    [Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis in human basophils by anti-Fas antibody treatment in vitro.
    Matsumoto K, Maeda A, Bochner BS, Wakiguchi H, Saito H.
    Int Arch Allergy Immunol; 2008 Apr 15; 146 Suppl 1():40-6. PubMed ID: 18504406
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
    Lin SJ, Lee CC, Cheng PJ, See LC, Kuo ML.
    Pediatr Allergy Immunol; 2009 Jun 15; 20(4):392-8. PubMed ID: 18713315
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.
    Gati A, Guerra N, Gaudin C, Da Rocha S, Escudier B, Lécluse Y, Bettaieb A, Chouaib S, Caignard A.
    Cancer Res; 2003 Nov 01; 63(21):7475-82. PubMed ID: 14612548
    [Abstract] [Full Text] [Related]

  • 17. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases.
    Akkoc T, de Koning PJ, Rückert B, Barlan I, Akdis M, Akdis CA.
    J Allergy Clin Immunol; 2008 Mar 01; 121(3):652-658.e1. PubMed ID: 18328893
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic deletion of faim reveals its role in modulating c-FLIP expression during CD95-mediated apoptosis of lymphocytes and hepatocytes.
    Huo J, Xu S, Guo K, Zeng Q, Lam KP.
    Cell Death Differ; 2009 Jul 01; 16(7):1062-70. PubMed ID: 19300454
    [Abstract] [Full Text] [Related]

  • 20. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death.
    Acosta-Rodríguez EV, Craxton A, Hendricks DW, Merino MC, Montes CL, Clark EA, Gruppi A.
    Eur J Immunol; 2007 Apr 01; 37(4):990-1000. PubMed ID: 17357108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.